Chinese Drug Developer I-Mab Biopharma Files for U.S. IPO

(Bloomberg) -- I-Mab Biopharma Co., a Chinese drug developer, has filed confidentially for a U.S. initial public offering as the company works on a private fundraising, according to people with kno...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.